PL417769A1 - Kompozycja aminokwasowa na bazie białka do stosowania przed wysiłkiem fizycznym - Google Patents

Kompozycja aminokwasowa na bazie białka do stosowania przed wysiłkiem fizycznym

Info

Publication number
PL417769A1
PL417769A1 PL417769A PL41776916A PL417769A1 PL 417769 A1 PL417769 A1 PL 417769A1 PL 417769 A PL417769 A PL 417769A PL 41776916 A PL41776916 A PL 41776916A PL 417769 A1 PL417769 A1 PL 417769A1
Authority
PL
Poland
Prior art keywords
amino acid
protein
amino acids
acid composition
composition based
Prior art date
Application number
PL417769A
Other languages
English (en)
Other versions
PL238958B1 (pl
Inventor
Piotr Kaczka
Katarzyna Kubicka
Amit Batra
Original Assignee
Olimp Laboratories Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olimp Laboratories Spółka Z Ograniczoną Odpowiedzialnością filed Critical Olimp Laboratories Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL417769A priority Critical patent/PL238958B1/pl
Priority to EP17176658.7A priority patent/EP3298908A3/en
Publication of PL417769A1 publication Critical patent/PL417769A1/pl
Publication of PL238958B1 publication Critical patent/PL238958B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest kompozycja aminokwasów, uzyskana poprzez połączenie dowolnych hydrolizatów źródeł białka albo dowolnych hydrolizatów źródeł białka i wolnych aminokwasów lub tylko wolnych aminokwasów, do stosowania przed wysiłkiem fizycznym. Kompozycja charakteryzuje się tym, że posiada profil aminokwasowy, w którym wzajemny stosunek wagowy poszczególnych aminokwasów jest identyczny z tym znajdowanym w płynie wewnątrzkomórkowym ludzkich komórek mięśniowych w stanie homeostazy.
PL417769A 2016-06-29 2016-06-29 Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym PL238958B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL417769A PL238958B1 (pl) 2016-06-29 2016-06-29 Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
EP17176658.7A EP3298908A3 (en) 2016-06-29 2017-06-19 Protein-based amino acid composition for use prior to exercise

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL417769A PL238958B1 (pl) 2016-06-29 2016-06-29 Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym

Publications (2)

Publication Number Publication Date
PL417769A1 true PL417769A1 (pl) 2018-01-03
PL238958B1 PL238958B1 (pl) 2021-10-25

Family

ID=59325112

Family Applications (1)

Application Number Title Priority Date Filing Date
PL417769A PL238958B1 (pl) 2016-06-29 2016-06-29 Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym

Country Status (2)

Country Link
EP (1) EP3298908A3 (pl)
PL (1) PL238958B1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
BR112020025831A2 (pt) * 2018-06-20 2021-03-23 Axcella Health Inc. métodos de fabricação de composições de aminoácidos
EP3976088A4 (en) * 2019-06-03 2023-10-11 Société des Produits Nestlé S.A. RECOVERY OF FOOD SUPPLEMENTS
IT201900010437A1 (it) * 2019-06-28 2020-12-28 Dompe Farm Spa Composizione per il trattamento del deperimento muscolare

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9121467D0 (en) * 1991-10-10 1991-11-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
JP5749419B2 (ja) * 2008-12-24 2015-07-15 雪印メグミルク株式会社 筋肉増強剤
EP2327316B1 (en) * 2009-11-29 2016-11-16 Premier Nutrition Corporation Method of enhancing muscle protein synthesis

Also Published As

Publication number Publication date
EP3298908A3 (en) 2018-04-25
EP3298908A2 (en) 2018-03-28
PL238958B1 (pl) 2021-10-25

Similar Documents

Publication Publication Date Title
EP3298908A3 (en) Protein-based amino acid composition for use prior to exercise
CU20190057A7 (es) Composiciones que comprenden aminoácidos
CL2017000201A1 (es) Composiciones y métodos de uso para tratar trastornos metabólicos
MX383537B (es) Mutantes de proteína f de rsv.
ECSP20011578A (es) Composiciones de aminoácidos para el tratamiento de enfermedad hepática
MX388858B (es) Reducción de la viscosidad de formulaciones farmacéuticas
FR3052453B1 (fr) Peptide, composition le comprenant et utilisations notamment cosmetiques
DOP2016000109A (es) Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas.
MX391216B (es) Composicion farmaceutica que comprende un vector adenoviral.
BR112017025813A2 (pt) método, kit ou composição, micróbio comensal benéfico, método para tratar ou prevenir o câncer e formulação bacteriana
MX384802B (es) Composicion que contiene quitina y proteinas digeribles.
EP3522882A4 (en) AMINO ACID COMPOSITIONS AND USES THEREOF
AR109799A1 (es) Composición para el tratamiento del cabello
BR112016023754A2 (pt) ?uso de lactobacillus paracasei para promover recuperação da diversidade da microbiota intestinal após disbiose?
CL2019002729A1 (es) Formulaciones de ácido 1-amino-1-ciclopropanocarboxílico.
BR112018003714A8 (pt) Composições de ácido de peso aumentado que compreendem aminoácidos
DOP2016000076A (es) Tienouracilcarboxamidas cíclicas y usos de las mismas
BR112018000594A2 (pt) composições nutricionais compreendendo caseína hidrolisada
EA201890439A1 (ru) ИММУНООНКОЛОГИЧЕСКАЯ МЕЗОДЕРМАЛЬНАЯ КЛЕТКА-ПРЕДШЕСТВЕННИК (ioMP-КЛЕТКА)
BR112015018265A2 (pt) Composições nutricionais contendo um componente peptídico com propriedades estimulantes de adiponectina e utilizações das mesmas
AR113514A1 (es) Composiciones y métodos para mejorar la utilización del fósforo y el calcio en la dieta de los animales
MY183391A (en) Refrigerant pack
CA3056612A1 (en) Analogs of deutetrabenazine, their preparation and use
PY1754642A (es) Métodos y composiciones para combinaciones de mutaciones asociados con resistencia / tolerancia a herbicidas en arroz
WO2017042198A3 (en) Agents and methods using thereof for the prevention and treatment of stem cell muscle disorders